| FROM
THE ARCHIVES OF
MONIQUE S. ROY, MD |
| |
BIOGRAPHICAL
SKETCH |
|
| |
TABLE: Statistical Analysis of SNPs Across the Human Genome for Association With Retinopathy (2009) |
|
| |
SELECTED
ARTICLES |
|
| |
|
|
| |
1. Roy M, Janal M, Roy A. Medical and psychological risk factors associated with incident hypertension in type 1 diabetic African Americans. Int J Hypertension. In press. |
|
| |
|
|
| |
2. Roy A, Roy M, Janal M. Suicide attempts and ideation in type 1 diabetic patients. Psychiatry Res. In press. |
|
| |
|
|
| |
3. Howson J, Roy M, Zeitels L, Stevens H, Walker N, Goldman D, Todd J. Dissections of HLA class II associations in type 1 diabetes in African Americans. Diabetologia. In press. |
|
| |
|
|
| |
4. Kolomeyer AM, Roy MS, Chu DS. The use of intravitreal ranibizumab for choroidal neovascularization associated with Vogt-Koyanagi-Harada syndrome. Case Report Med. 2011;2011:747648. |
|
| |
|
|
| |
5. Roy M , Klein R, Janal M. Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes. Arch Ophthalmol. 2011;129:8-15. |
|
| |
|
|
| |
6. Roy M, Hallman DM, Fu Y-P, Machado M, Hanis C. Assessment of 193 candidate genes for diabetic retinopathy in African-Americans with type 1 diabetes. Arch Ophthalmol 2009;127:605-12. |
|
| |
|
|
| |
7. Pachydaki S, Klaver C, Barbazetto I, Roy M, Gouras P, Allikmets R, Yannuzzi L. Phenotypic features of patients with NR2E3 mutations. Arch Ophthalmol 2009;127;71-5. |
|
| |
|
|
| |
8. Roy MS, Peng B. Six year incidence of lower extremity arterial disease and associated risk factors in type 1 diabetic African-Americans. Diab Med 2008;25:550-6. |
|
| |
|
|
| |
9. Roy M, Peng B, Roy A. Risk factors for coronary disease and stroke in previously hospitalized African-Americans with type 1 diabetes: a 6-year follow-up. Diab Med 2007;24:1361-8. |
|
| |
|
|
| |
10. Roy M, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med 2007;69:537-42. |
|
| |
|
|
| |
11. Roy M, Affouf M, Roy A. Six-year incidence of proteinuria in type 1 diabetic African Americans. Diabetes Care 2007;30:1807-12. |
|
| |
|
|
| |
12. Roy MS, Skurnick J. Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 2007;125:1061-7. |
|
| |
|
|
| |
13. Roy M, Affouf M. Six-year progression of retinopathy and associated risk factors in African-Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol 2006;124:1297-306. |
|
| |
|
|
| |
14. Roy M, Rendas-Baum R, Skurnick J. Mortality in African-Americans with type 1 diabetes: the New Jersey 725. Diabetic Med 2006;23:698-706. |
|
| |
|
|
| |
15. Roy M, Roy A. No relationship between cholesterol and depression and suicidal ideation in African-Americans with type 1 diabetes. Arch Suicidal Res 2006;10:11-4. |
|
| |
|
|
| |
16. Roy M. Eye care in African-Americans with type 1 diabetes: the New Jersey 725. Ophthalmology 2004;111: 914-20. |
|
| |
|
|
| |
17. Roy M, Klein R, O’Colmain B. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 2004;122:546-51. |
|
| |
|
|
| |
18. Roy M. Proteinuria in African-Americans with type 1 diabetes: the New Jersey 725. J Diabetes Complications.
2004;18:69-77. |
|
| |
|
|
| |
19. Roy A, Roy M, Berman
J, Gonzalez B. Cone electroretinogram amplitudes are related to
dopamine function in cocaine- dependent patients. Psychiatry Res 2003;117:191-5. |
|
| |
|
|
| |
20. Roy A, Berman J, Gonzalez B,
Roy M. CSF monomine metabolites in cocaine patients: no relationship
to cue-induced craving. J Psychopharmacol
2002;16:227-9. |
|
| |
|
|
| |
21. Roy M. Frequency and
risk factors associated with macular edema in African-Americans
with type I diabetes: the New Jersey 725. Excerpta Medica 2002;9:7-10. |
|
| |
|
|
| |
22. Smelson
D, Roy A, Roy M, Habib C, Engelhart C, Losonczy M. Electroretinogram
and cue elicited craving in withdrawn cocaine patients: a replication.
Am J Drug Alcohol Abuse 2001;27:391-7. |
|
| |
|
|
| |
23. Roy MS. Prevalence
and risk factors for proteinuria in African-Americans with type
1 diabetes; relationship to diabetic retinopathy: The New Jersey
725. Invest Ophthalmol Vis Sci 2001;42(4 Suppl):S698. |
|
| |
|
|
| |
24. Roy, M. Diabetic
retinopathy in African-Americans with type I diabetes: The New
Jersey 725. II. Risk factors. Excerpta Medica 2001;8:14. |
|
| |
|
|
| |
25. Roy, M. Diabetic
retinopathy in African-Americans with type I diabetes: The New
Jersey 725. I. Methodology, population,frequency of retinopathy
and visual impairment. Excerpta Medica 2001;8:14. |
|
| |
|
|
| |
26. Roy A, Roy M.
Depressive symptoms in African-American type 1 diabetics. Depression
and Anxiety 2001;13:28-31. |
|
| |
|
|
| |
27. Roy M, Klein
R. Macular edema and retinal hard exudates in African-Americans
with type 1 diabetes: the New Jersey 725. Arch Ophth 2001;119:251-9. |
|
| |
|
|
| |
28. Roy M. Diabetic
retinopathy in African-Americans with type 1 diabetes: the New
Jersey 725. II. Risk factors. Arch Ophth 2000;118:105-15. |
|
| |
|
|
| |
29. Roy M. Diabetic
retinopathy in African-Americans with type 1 diabetes: the New
Jersey 725: I. Methodology, population, frequency of retinopathy,
and visual impairment. Arch Ophth 2000;118:97-104. |
|
| |
|
|
| |
30. Abdelsalam A, Gonalez
C, Del Priore L, Roy M. Unsuspected metallic intraocular
foreign body associated with blurry visual acuity and depressed
ERG. Invest Ophthalmol Vis Sci 2000;41(Suppl):S1838. |
|
| |
|
|
| |
31. Roy M, Klein
R, Parides M. Macular edema in African-Americans with type I diabetes:
The New Jersey 725. Invest Ophthalmol Vis Sci 2000;41(Suppl):S3469. |
|
| |
|
|
| |
32. Roy M and
Borenstein M. Visual impairment in African-American with type
I diabetes: the New Jersey 725. Invest Ophthalmol Vis Sci 1999;40(Suppl):S372. |
|
| |
|
|
| |
33. Smelson D, Roy
M, Roy A and Santana S. Electroretinogram in withdrawn
cocaine-dependent patients: relationship to cue-elicited craving.
Brit J Psychiatry 1998;172:537-9. |
|
| |
|
|
| |
34. Roy A, Roy M,
Smelson D. Risperidone, ERG and cocaine craving. Am J Addiction
1998;7:90. |
|
| |
|
|
| |
35. Fleckner M, Roy
M. Effect of refractive error on retinal microcirculation:
a blue field simulation study. Invest Ophthalmol Vis Sci 1998;39(Suppl):S267. |
|
| |
|
|
| |
36. Roy M, Borenstein
M, Klein R. Treatment risk factors for diabetic retinopathy in
African-American with type 1 diabetes: the New Jersey Study. Invest
Ophthalmol Vis Sci 1998;39(Suppl):S193. |
|
| |
|
|
| |
37. Smelson D, Roy
A, Roy M. Risperidone and neuropsychological
test performance in cocaine addicts. Can J Psychiatry 1997;42:431-5. |
|
| |
|
|
| |
38. Smelson D, Roy
A, Roy M. Risperidone and neuropsychological
functioning in cocaine addicts. Can J Psychiatry 1996;42:415-21. |
|
| |
|
|
| |
39. Roy M,
Roy A. Abnormal ERG in cocaine-dependent patients: relationship
to craving. Br J Psychiatry 1996;168:507-11. |
|
| |
|
|
| |
40. Roy M,
Gascon P. Macular blood flow velocity in sickle cell patients:
relationship to red cell density. Br J Ophthalmol 1995;79:742-5. |
|
| |
|
|
| |
41..Roy M,
Roy A. Factitious hypoglycemia: an eleven-year follow-up. Psychosomatics
1995;36:1-2. |
|
| |
|
|
| |
42. Roy M,
Collier B, Roy A. Excess of decompressive symptoms and life events
among diabetic outpatients: a preliminary study. Comp Psychiatry
1994;34:129-31. |
|
| |
|
|
| |
43. Roy
M, Collier B, Roy A. Plasma cortisol and ACTH levels
and duration of diabetes. J Diabetic Compl 1992;5:218-20. |
|
| |
|
|
| |
BOOKS, MONOGRAPHS AND CHAPTERS |
|
| |
|
|
| |
1. Roy M, MacKay CJ, and Gouras P. Detecting blue cone monochromats by electroretinopathy. In: Cavonius CR, editor. Color vision deficiencies XIII. Kluwer Academic; 1997. p 409-413. |
|
| |
|
|
| |
2. Gouras P, MacKay CJ, Roy M, Saeki M, and Yamamoto S. Retinal and brain responses of S-cones. In: Drum B, editor. Color vision deficiencies XII. Kluwer Academic; 1994. p 353-364. |
|
| |
|
|
